Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice
Hitoshi Hasegawa(Tokyo Institute of Psychiatry), Shigeru Fujita(Tokyo Medical University), Jun‐ichi Miyazaki(The University of Osaka), Hiroki Maruyama(Niigata University), Mitsuko R. Ito(Tohoku University), Miho Sasaki(Ehime University), Miho Terada(Ehime University), Atsushi Inoue(Astellas Pharma (Japan)), Masato Nose(Meiji University), Kunio Hieshima(Kumamoto Orthopedic Surgery Hospital), Masashi Kohno(Ehime University), Osamu Yoshie(Waseda University)
Cited by 148
Related Papers
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
|Immunity|1999|2.7k
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion
|Cell|1997|1.5k
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
Human host factors required for influenza virus replication
|Nature|2009|825